Suh-Burgmann, E., Hung, Y.Y. and Armstrong, M.A. (2009) Complex Atypical Endometrial Hyperplasia: The Risk of Unrecognized Adenocarcinoma and Value of Preoperative Dilation and Curettage. Obstetrics & Gynecology, 114, 523-529.
http://dx.doi.org/10.1097/AOG.0b013e3181b190d5

has been cited by the following article:

• TITLE: Is the Use of Frozen Section Indispensable in the Surgical Treatment of Endometrial Hyperplasia?

  AUTHORS: Ceyhun Numanoglu, Dilek Marangoz Chapman, Aysun Fendal Tunca, Aysu Akca, Agahan Han, Volkan Ulker, Ozgur Akbayir

  KEYWORDS: Endometrial Hyperplasia, Coexisting Endometrial Cancer, Atypical Endometrial Hyperplasia, Frozen Section, Hysterectomy

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.5 No.4, April 14, 2015

  ABSTRACT: Objective: To evaluate the reliability and accuracy of frozen section (FS) compared with final pathology and to determine whether they should be obligatory in every patient with atypical endometrial hyperplasia (AEH). Methods: We retrospectively assessed the medical records of 192 patients whose endometrial biopsy results were endometrial hyperplasia and underwent hysterectomy at our center. Results: Twenty-two (11.4%) of the 192 patients in our study had concurrent endometrial carcinoma (EC). Of these, 21 (95.5%) were EC and 1 (4.5%) was non-endome- trioid. Of the 140 patients with AEH, 20 (14.3%) had concurrent EC. Overall, 157 patients had FS. Two (1%) patients’ EC was higher than grade 1B and needed lymphadenectomy. The positive and negative predictive value, specifity and sensitivity of FS were found to be 77.8%, 95.7%, 97% and 70%, respectively. Conclusion: Patients who have AEH without high-risk comorbidities do not have to be referred to oncology centers and can undergo hysterectomy in community hospitals without FS.